CoChat

Remote Blood Biomarkers of Longitudinal Cognitive Outcomes in a Population Study

Open access
Rajan, Kumar B., Aggarwal, Neelum T., McAninch, Elizabeth A., Weuve, Jennifer, Barnes, Lisa L., Wilson, Robert S., DeCarli, Charles, Evans, Denis A. · 2020 · Annals of Neurology
Cited by 147

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Objective: The longitudinal association of the blood biomarkers total tau (t‐tau), neurofilament light (Nf‐L), and glial fibrillary acidic protein (GFAP) with common sporadic Alzheimer disease (AD) and cognitive decline is not established. Methods: Using a single molecule array technology, ultrasensitive immunoassays for serum concentrations of t‐tau, Nf‐L, and GFAP were measured in a population sample of 1,327 participants (60% African Americans and women) who had a clinical evaluation for AD, had completed in‐home cognitive assessments, and had undergone 1.5T structural magnetic resonance imaging. Results: Higher concentrations of serum biomarkers were associated with the development of clinical AD; especially, the time‐specific associations were notable: t‐tau 8 to 16 years, and Nf‐L and GFAP 4 to 8 years prior to clinical AD. Serum biomarkers were associated with faster cognitive decline over 16 years; baseline t‐tau > 0.40pg/ml had 30% faster decline, Nf‐L > 25.5pg/ml had 110% faster decline, and GFAP > 232pg/ml had 130% faster decline compared to those in the lowest quartile. Participants with baseline GFAP > 232pg/ml showed 160% faster decline in hippocampal volume compared to those with values < 160pg/ml. Additionally, higher baseline t‐tau was associated with faster increase in 3rd ventricular volume, and baseline Nf‐L and GFAP were associated with faster decline in cortical thickness. Interpretation: Serum t‐tau, Nf‐L, and GFAP predict the development of sporadic AD and cognitive decline, and changes in structural brain characteristics, suggesting their usefulness not only as screening and predictive biomarkers, but also in capturing the pathogenesis of Alzheimer dementia. ANN NEUROL 2020;88:1065–1076

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.25874

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 147

Metadata

Authors
Rajan, K. B., Aggarwal, N. T., McAninch, E. A., Weuve, J., Barnes, L. L., Wilson, R. S., DeCarli, C., & Evans, D. A.
Venue
Annals of Neurology
Publisher
Wiley
Published
2020-09-29
Volume
88
Issue
6
Pages
1065-1076
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W3049747840
Cited by
147
References
13
FWCI
13.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.